In diabetes war, Novo Nordisk aims to break mold with new pill
LONDON: After nearly a century building a company worth $125 billion based on injectable drugs,… Read More
8 years ago
LONDON: After nearly a century building a company worth $125 billion based on injectable drugs,… Read More